Compare GeneDx Holdings Corp (WGS) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? GeneDx Holdings Corp trades at $69.42 (market cap $2.02B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.6 (market cap $330.98M). The key difference: GeneDx Holdings Corp is far larger — about 6.1× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and GeneDx Holdings Corp is more actively traded (734,640 versus 194,030). Which is the better fit depends on your goals — on Pluang, investors hold GeneDx Holdings Corp for 19 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| WGS | XDTE | |
|---|---|---|
Market Cap | $2.02B | $330.98M |
Volume | 734,640 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $167.51 | $44.76 |
52-Week Low | $34.51 | $36.00 |
Typical Hold Time | 19 Days | 54 Days |
Enterprise Value | $2.05B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx Holdings Corp. (WGS) trades at $68.53, down 4.18% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $21.02 million for 2025, though Q2 2026 earnings beat expectations. Revenue growth is positive, but profitability remains a challenge with negative margins. Analyst consensus is strongly bullish with a $81.00 price target, supported by recent product launches and institutional interest.
The outlook hinges on execution toward profitability amid high cash burn. Investment opportunity lies in the genomic testing market expansion and analyst optimism, but risks include sustained losses, competitive pressure, and reliance on financing. The stock's trajectory will depend on achieving projected margin improvements and revenue scalability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
